Paraganglioma Forecast Report 2025 – Designed for Product & Growth Teams

 

  Paraganglioma Market Size and growth rate 2025 to 2029: Graph


This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Paraganglioma industry.
 
 #What is the current market size of the paraganglioma industry, and what growth rate is it expected to achieve?#
 The paraganglioma market size has grown strongly in recent years. It will grow from $2.89 billion in 2024 to $3.03 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to advancements in diagnostic imaging, increasing awareness & screening programs, regulatory approvals for targeted therapies, growth in specialized treatment centers, and advancements in genetic testing.
 
 The paraganglioma market size is expected to see strong growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to emerging targeted therapies & immunotherapies, expansion of radiopharmaceuticals, rising prevalence of genetic disease, growing investments in rare disease research, and improved healthcare access in emerging markets. Major trends in the forecast period include advancements in targeted therapies, expansion of radiopharmaceuticals, the rise of immunotherapy approaches, improved artificial intelligence (AI) in diagnostics, and the development of minimally invasive surgical techniques.
 
 #Download Your Free Sample PDF:#
 https://www.thebusinessresearchcompany.com/sample.aspx?id=21245&type=smp
 
 #What are the major drivers contributing to the growth of the paraganglioma market?#
 The increasing investments on oncology research and medicine is expected to propel the growth of the paraganglioma market going forward. Investments in oncology research and medicine refer to financial allocations made by governments, pharmaceutical companies, research institutions, and private investors to advance the understanding, prevention, diagnosis, and treatment of cancer. The increasing investments in oncology research and medicine are due to the rising global cancer burden, advancements in precision medicine, growing demand for innovative therapies, expanding clinical trials, government and private funding initiatives, and the development of targeted and immunotherapy treatments. Investments in oncology research and medicine support paraganglioma by driving advancements in early diagnosis, enhancing treatment options such as targeted therapies and immunotherapy, funding clinical trials for more effective drugs, improving pediatric cancer care infrastructure, and fostering innovative research to better understand the disease’s biology and progression. For instance, in May 2024, according to the IQVIA, an India-based information technology company providing advanced analytics, global spending on cancer medicine rose to $223 billion in 2023, marking a $25 billion increase from 2022, and is expected to reach $409 billion by 2028. Therefore, the increasing investments on oncology research and medicine drives the paraganglioma market.
 
 #What are the major market segments driving the growth of the paraganglioma industry?#
 The paraganglioma market covered in this report is segmented –
 
 1) By Type: Sympathetic Paragangliomas, Parasympathetic Paragangliomas, Caroid Paragangliomas, Cervical Paragangliomas, Jugular Paragangliomas, Secretory Paragangliomas, Temporal Paragangliomas
 2) By Origin: Head And Neck, Abdomen, Pelvis, Other Origins
 3) By Treatment Type: Peptide Receptor Radionuclide Therapy, Surgery, Chemotherapy, Radiation Therapy, Other Treatment Types
 4) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies
 5) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes, Other End-Users
 
 Subsegments:
 1) By Sympathetic Paragangliomas: Adrenal Sympathetic Paragangliomas, Extra-Adrenal Sympathetic Paragangliomas
 2) By Parasympathetic Paragangliomas: Head And Neck Parasympathetic Paragangliomas, Thoracic Parasympathetic Paragangliomas
 3) By Carotid Paragangliomas: Unilateral Carotid Paragangliomas, Bilateral Carotid Paragangliomas
 4) By Cervical Paragangliomas: Vagal Paragangliomas, Hypoglossal Paragangliomas
 5) By Jugular Paragangliomas: Type A, Type B, Type C, Type D
 6) By Secretory Paragangliomas: Catecholamine-Secreting Paragangliomas, Non-Catecholamine-Secreting Paragangliomas
 7) By Temporal Paragangliomas: Tympanic Paragangliomas, Mastoid Paragangliomas
 
 #View The Full Market Report:#
 https://www.thebusinessresearchcompany.com/report/paraganglioma-global-market-report
 
 #What are the most notable trends influencing investment in the paraganglioma sector?#
 Major companies operating in the paraganglioma market are focusing on developing advanced therapies such as oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitors to offer targeted therapy options for patients with paraganglioma. An oral HIF-2α inhibitor is a targeted therapy that suppresses HIF-2α activity, a key factor in tumor growth under low-oxygen conditions, helping to slow the progression of cancers like paraganglioma. For instance, in January 2025, Merck, a US-based biopharmaceutical company, announced a priority review for its supplemental new drug application for Welireg (belzutifan), which is granted by the U.S. Food and Drug Administration (FDA), a US-based government agency. It is designed for adult and pediatric patients (12 years and older) with advanced, unresectable, or metastatic pheochromocytoma and paraganglioma (PPGL). The sNDA is based on objective response rate (ORR) and duration of response (DOR) data from the Phase 2 LITESPARK-015 trial.
 
 #Who are the key market players contributing to the growth of the paraganglioma industry?#
 Major companies operating in the paraganglioma market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc. , Mount Sinai, Penn Medicine, Stanford Health Care, St. Jude Children’s Research Hospital, UT Health San Antonio, The University of Chicago Medical Center, Fred Hutchinson Cancer Center, Florida Cancer Specialists & Research Institute, Invitae Corp., Clinigen Group plc, Fulgent Genetics, Dana-Farber Cancer Institute Inc., Oncology Hematology Care Inc., Enterome , National Institutes of Health Clinical Center, Progenics Pharmaceuticals Inc., Pheo Para Alliance, Saint John’s Cancer Institute
 
 #Which regions are leading the growth of the paraganglioma market globally?#
 North America was the largest region in the paraganglioma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paraganglioma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 #How Can Companies Use The Paraganglioma Market Report to Drive Business Results?#
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 #Purchase The Report And Get A Swift Delivery:#
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21245
 
 #Need Customized Data On Paraganglioma Market?#
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 #Request Customized Data:#
 https://www.thebusinessresearchcompany.com/customise?id=21245&type=smp
 
 #About The Business Research Company:#
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 #Contact Us:#
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 #Follow Us On:#
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

 

Comments

Post a Comment

Popular posts from this blog

Gear Box And Gear Motor Market 2024-2033: Technological Advancements, Competitive Landscape and Strategies

Image
  The gear box and gear motor global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market. Gear Box And Gear Motor Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities. Market Size - The gear box and gear motor market size has grown strongly in recent years. It will grow from $16.3 billion in 2023 to $17.22 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rapid growth in heavy machinery, early adoption in aviation and aerospace, pioneering industry applications, world ...
Read more

Predicted Growth Surge in Phase Change Materials Market to $4.24 Billion by 2029: Main Drivers, Trends, and Forecast

Image
  What's the Phase Change Materials Market Future? The phase change materials market size has demonstrated rapid growth over recent years and is set to continue this trend. It will expand from $1.84 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 19.2%. This historic period growth is attributed to energy-efficient building construction, temperature regulation in electronics, thermal management in food preservation, growth in green building standards, energy storage and HVAC applications. Meanwhile, the market size is predicted to see accelerated growth in the next few years, rising to $4.24 billion in 2029 at a CAGR of 18.0%. The forecast period growth can be traced back to integration into wearable technology, advanced phase change materials for EVs, smart textiles and clothing, growth in data centers and cloud computing, and expansion of renewable energy storage. Get Your Free Sample of The Global Phase Change Materials Market Report: h...
Read more

Vehicle Intrusion Detection Market Size to Grow Steadily, Projected to Hit $3.73 Billion by 2029 at 6.2% CAGR

Image
    The Business Research Company’s report on the Vehicle Intrusion Detection Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.    What are the primary drivers fueling the growth of the vehicle intrusion detection market in recent years?  The increasing number of vehicle theft and security concerns are expected to propel the growth of the vehicle intrusion detection market going forward. Vehicle theft and security concerns refer to the rising risks associated with unauthorized access, tampering, or theft of vehicles, which pose significant challenges to individual owners and the automotive industry. The increasing vehicle theft and security concerns are due to the rise in sophisticated theft techniques, such as keyless entry hacks and cyberattacks on connected car systems, which exploit vulnerabilities in modern vehicle technologies. Vehi...
Read more